JB Chemicals and Pharmaceuticals

1 insight

Brewed Up Insights

Torrent's Q2 FY27 sales rose 51%, per-share profit fell 19%

Torrent Pharma's sales rose 51% after it bought J.B. Chemicals. But the deal's interest, write-downs and new shares cut its profit per share by 19%.

Read more →

3 charts

2 stacks of Torrent Pharma's sales: ₹3,302 crore from its own business in July to September 2025, then ₹3,893 crore from its own business plus ₹1,086 crore from J.B. in the same months of 2026, ₹4,979 crore in all.Most of Torrent Pharma's 51% sales growth came from buying J.B.Pairs of bars for Torrent Pharma: borrowings up from ₹2,590 crore in September 2025 to ₹13,874 crore in September 2026, and intangible assets up from ₹3,911 crore to ₹23,352 crore.Torrent Pharma's borrowings rose 5.4x in the year it bought J.B.A bar of Torrent Pharma's 38.04 crore shares: 33.85 crore held by its shareholders before the merger and 4.19 crore issued to J.B.'s shareholders, 11% of the whole.Former J.B. shareholders now own 11% of Torrent Pharma

Every company we have written about →

Get in touch